Cytori Cell Research Institute, Inc. (3750.T)
JPY 916.0
(-1.51%)
JPY 916.0
(-1.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.02 Billion JPY | -73.58% |
| 2022 | 11.43 Billion JPY | -6.96% |
| 2021 | 12.29 Billion JPY | 8.04% |
| 2020 | 11.37 Billion JPY | -2.36% |
| 2019 | 11.65 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.83 Billion JPY | -6.18% |
| 2023 Q3 | 11.63 Billion JPY | 2.19% |
| 2023 FY | 3.02 Billion JPY | -73.58% |
| 2023 Q4 | 3.02 Billion JPY | -74.04% |
| 2023 Q2 | 11.38 Billion JPY | 0.22% |
| 2023 Q1 | 11.35 Billion JPY | -0.66% |
| 2022 Q3 | 11.08 Billion JPY | 0.0% |
| 2022 Q2 | 11.08 Billion JPY | 0.0% |
| 2022 Q4 | 11.43 Billion JPY | 3.16% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 3.24 Billion JPY | 6.966% |
| PRISM BioLab Co.,LTD | 63.41 Million JPY | -4663.76% |
| GNI Group Ltd. | 26.34 Billion JPY | 88.532% |
| Linical Co., Ltd. | 10.3 Billion JPY | 70.686% |
| Trans Genic Inc. | 3.81 Billion JPY | 20.768% |
| MEDINET Co., Ltd. | 590.2 Million JPY | -411.814% |
| Soiken Holdings Inc. | 697.02 Million JPY | -333.379% |
| AnGes, Inc. | 2.78 Billion JPY | -8.295% |
| OncoTherapy Science, Inc. | 513.6 Million JPY | -488.144% |
| Nxera Pharma Co., Ltd. | 90.38 Billion JPY | 96.658% |
| Immuno-Biological Laboratories Co., Ltd. | 353.27 Million JPY | -755.08% |
| NanoCarrier Co., Ltd. | 1.64 Billion JPY | -83.088% |
| Carna Biosciences, Inc. | 472.35 Million JPY | -539.508% |
| CanBas Co., Ltd. | 91.98 Million JPY | -3183.85% |
| D. Western Therapeutics Institute, Inc. | 1.09 Billion JPY | -176.219% |
| RaQualia Pharma Inc. | 809.83 Million JPY | -273.01% |
| Chiome Bioscience Inc. | 593.73 Million JPY | -408.774% |
| Kidswell Bio Corporation | 4.25 Billion JPY | 28.992% |
| PeptiDream Inc. | 29.11 Billion JPY | 89.625% |
| Oncolys BioPharma Inc. | 566.5 Million JPY | -433.23% |
| Ribomic Inc. | 155.8 Million JPY | -1838.751% |
| SanBio Company Limited | 2.25 Billion JPY | -33.964% |
| Healios K.K. | 11.28 Billion JPY | 73.235% |
| BrightPath Biotherapeutics Co., Ltd. | 251.26 Million JPY | -1102.197% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 369 Million JPY | -718.631% |
| Delta-Fly Pharma, Inc. | 241.49 Million JPY | -1150.843% |
| StemRIM | 187 Million JPY | -1515.373% |
| CellSource Co., Ltd. | 677.73 Million JPY | -345.71% |
| FunPep Company Limited | 189.32 Million JPY | -1495.544% |
| Kringle Pharma, Inc. | 596.95 Million JPY | -406.026% |
| Stella Pharma Corporation | 1.44 Billion JPY | -109.25% |
| TMS Co., Ltd. | 97.68 Million JPY | -2992.209% |
| Noile-Immune Biotech Inc. | 91.49 Million JPY | -3201.58% |
| Cuorips Inc. | 200.96 Million JPY | -1403.151% |
| K Pharma,Inc. | 209.13 Million JPY | -1344.408% |
| Takara Bio Inc. | 11.42 Billion JPY | 73.549% |
| ReproCELL Incorporated | 741.03 Million JPY | -307.641% |
| PhoenixBio Co., Ltd. | 917.71 Million JPY | -229.16% |
| StemCell Institute Inc. | 3.85 Billion JPY | 21.548% |
| Japan Tissue Engineering Co., Ltd. | 908.43 Million JPY | -232.524% |
| CellSeed Inc. | 301.04 Million JPY | -903.414% |